Market Place
Sourcing Support
CytoReason Raises $80M To Scale AI Models And Open US Hub
17 Jul 2024 //
BUSINESSWIRE
CytoReason Licenses IBD Disease Model to Sanofi in Expanded Alliance
23 Jan 2023 //
CONTRACT PHARMA
CytoReason, Pfizer ink $110M extension of AI collab
21 Sep 2022 //
FIERCEBIOTECH
CytoReason Announces Expanded Collaboration Deal with Pfizer
20 Sep 2022 //
GLOBENEWSWIRE
CytoReason Extends multi-Year Partnership with Pfizer
20 Sep 2022 //
CONTRACTPHARMA
CytoReason expands reach in Asia
13 Apr 2022 //
BIOSPECTRUMASIA
CytoReason Expands Its Reach in Asia, Forging Commercial Alliance with Helixrus
12 Apr 2022 //
PRNEWSWIRE
Pfizer extends deal with Israeli AI firm
21 Feb 2022 //
AUSTRALIANJEWISHNEWS
Pfizer re-ups collab with AI disease model maker CytoReason
10 Feb 2022 //
FIERCEBIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.